CorConsult Rx: Evidence-Based Medicine and Pharmacy
Exxua (gepirone): the newly approved antidepressant
October 25, 2023
On this episode, we discuss the 5-HT1A receptor agonist, Exxua (gepirone). Exxua was recently FDA approved for the treatment of general depression. We review the long road this medication took to get
Evidence-based medicine and drug updates for pharmacists, physicians, NPs, PA-Cs, and students that are on the go.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast